Skip to content
Parker Institute for Cancer Immunotherapy
Search Close

Year In Review — PICI’s Progress in 2023

Accelerating new cancer research and discoveries: PICI’s impact in 2023

The Parker Institute for Cancer Immunotherapy’s (PICI) mission has always been to break down barriers and drive patient impact. Our North Star is the delivery of curative treatments to as many patients as possible. Since our inception in 2016, PICI has proudly laid the groundwork to foster unprecedented collaborations and accelerate breakthrough treatments for cancer patients. To support our mission, visit

At the core of PICI is the work of our academic research centers, world leaders in immuno-oncology, autoimmunity, synthetic biology, and other frontiers in medicine. Pioneering a novel collaboration model, we fund ambitious research programs and help steward our investigators’ scientific discoveries for rapid and meaningful patient impact.

PICI has supported more than 425 research projects and clinical trials, engaging nearly 800 of the world’s top oncology investigators and early career researchers. Our progress to date has been incredible, with a focus on Network growth, supporting groundbreaking research, and continuing to build collaboration and community in immuno-oncology.

2023 was no exception for us in driving impact in the field. Here’s a look back at some of our PICI Network achievements: